No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Mycobutin (Rifabutin) is an antibiotic used to treat a variety of bacterial infections. It is a member of the rifamycin class of antibiotics, which are used to treat tuberculosis, leprosy, and other mycobacterial infections. Mycobutin is also used to prevent Mycobacterium avium complex (MAC) infections in people with HIV. It works by inhibiting the growth of bacteria, thus preventing the spread of infection.
Mycobutin is available in both oral and injectable forms. It is typically prescribed for short-term use, as long-term use can lead to the development of drug-resistant bacteria. Common side effects include nausea, vomiting, and diarrhea.
The Mycobutin market is highly competitive, with many companies offering generic versions of the drug. Major players in the market include Pfizer, GlaxoSmithKline, Merck, and Sanofi. Other companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more
